Department of Radiology, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, No. 37 Guoxue Xiang, Chengdu, 610041, China.
Department of Cardiology, West China Hospital, Sichuan University, Chengdu, China.
Heart Fail Rev. 2020 Sep;25(5):847-860. doi: 10.1007/s10741-019-09846-6.
A systematic review and meta-analysis were performed to analyse the differences in clinical profiles between takotsubo syndrome (TTS) and acute coronary syndrome (ACS) patients and to consolidate the evidence regarding the mortality predictors in TTS patients. Literature search of PubMed, EMBASE and the Cochrane Central Register was made, and 55 studies with a total of 66,653 TTS patients were included. Compared with ACS subjects, TTS subjects had significantly lower left ventricle ejection fraction (LVEF) values on admission; however, cardiovascular risks were fewer and the recovery LVEF was notably higher at both discharge and follow-up in TTS patients than in ACS patients (all P < 0.05). No significant differences were observed either in-hospital mortality or long-term mortality between the two groups (both P > 0.05). Acute renal failure and malignancies were independent predictors of all-cause in-hospital mortality in TTS patients (both P < 0.05). Male sex (HR = 0.565, 95% CI 0.253-0.876, P < 0.001, I = 0.00%), advanced age (HR = 0.054, 95% CI 0.041 to 0.067, P < 0.001, I = 0.00%), shock (HR = 1.382. 95% CI 1.050 to 1.714, P < 0.001, I = 0.00%) and initial LVEF < 35% (HR = 0.962, 95% CI 0.948 to 0.977, P < 0.001, I = 16.8%) were associated with an increased risk of long-time mortality in TTS patients. In conclusion, TTS has significantly different clinical characteristics than ACS. However, the in-hospital and long-term overall mortality rates are not trivial for TTS patients, and some presenting features (underlying diseases, male sex, advanced age, low LVEF and shock) were significantly associated with all-cause mortality.
进行了系统评价和荟萃分析,以分析心尖球囊综合征(TTS)和急性冠状动脉综合征(ACS)患者之间的临床特征差异,并整合 TTS 患者死亡率预测因素的证据。对 PubMed、EMBASE 和 Cochrane 中央登记册进行了文献检索,共纳入 55 项研究,共计 66653 例 TTS 患者。与 ACS 患者相比,TTS 患者入院时左心室射血分数(LVEF)值明显较低;然而,心血管风险较少,TTS 患者在出院时和随访时的恢复 LVEF 明显高于 ACS 患者(均 P<0.05)。两组患者的住院死亡率或长期死亡率均无显著差异(均 P>0.05)。急性肾衰竭和恶性肿瘤是 TTS 患者全因住院死亡率的独立预测因素(均 P<0.05)。男性(HR=0.565,95%CI 0.253-0.876,P<0.001,I=0.00%)、高龄(HR=0.054,95%CI 0.041-0.067,P<0.001,I=0.00%)、休克(HR=1.382,95%CI 1.050-1.714,P<0.001,I=0.00%)和初始 LVEF<35%(HR=0.962,95%CI 0.948-0.977,P<0.001,I=16.8%)与 TTS 患者长期死亡率增加相关。总之,TTS 与 ACS 有明显不同的临床特征。然而,TTS 患者的住院和长期总死亡率并不低,一些表现特征(潜在疾病、男性、高龄、低 LVEF 和休克)与全因死亡率显著相关。